Vidavo
Vidavo (VIDAVO) closed at €9.50 on 06/11/2026, +2.15% on the day. Market cap €9.9m.
VIDAVO +16.6% (€8.15 → €9.50) · General Index —
Deepest fall inside it: −13.9% (9 Sep → 4 Nov 2026)
Drag across the chart to measure any stretchSlide sideways across the chart to measure
Key statistics
12 months to Jun 2026 unless a figure says otherwise
Profile
At the 6 Nov close- Market value
- Enterprise valueJun 2026est.
- Shares outstandingJun 2026
- Revenue12 months to Jun 2026
- Employees
- Free floatest.
- Traded a day, 3-month average
Valuation
12 months to Jun 2026- P/B
- EV/Salesest.
- EV/EBITDAest.
- P/FCF
- Dividend yield
5 years, on reported full years: 9.8–984.3×, median 22.5×. Today 11.3×, lower than 88% of months.
Margins
12 months to Jun 2026- EBITDA
- Operating (EBIT)
- Net
- Free cash flow
Net margin = the shareholders' profit ÷ group revenue.
Returns
12 months to Jun 2026- ROE
- ROCE
- ROICest.
- ROE, 5-year averageFY2021–25
Financial health
Jun 2026- Net debt
- Net debt ÷ EBITDA
- Interest cover12 months to Jun 2026
Growth
- Revenue, last yearFY2025
- Revenue, last halfH1 2026
- —
- Revenue, 3 yearsFY2022–25, a year
- Shares, 3 yearsFY2022–25
not meaningful here
Dividends
FY2025- Yield, last 12 months
- Per share
- Payout
- —
- Covered by free cash flow
- —
- Years paid, last fiveFY2021–25
nothing paid in 12 months
not meaningful here
Trading and risk
From our closes, dividends reinvested- Total return, 1 year
- +77.6%
- 3 years, a year
- +52.5%
- 5 years, a year
- +12.8%
- 10 years, a year
- +9.2%
- Volatility, 1 year
- 40.6%
- Beta to the General Index
- 0.11×
- Deepest fall, 1 year / 5 years
- −19.5% / −61.5%
- 52-week range
- €5.35–€10.80
Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.
Financial charts
From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements
Loading the charts…
Valuation
no like-for-like peer| Metric | VIDAVO |
|---|---|
| P/B | 4.5 |
| P/S | 2.4 |
| EV/EBITDA | 5.0 |
| Dividend yield | 0.0% |
| Operating margin | 40.6% |
| Net margin | 32.1% |
| ROE | 60.4% |
| Revenue growth (last full year) | 97.4% |
| Net debt | −€1.3m |
Peers: Digital health
No other company listed in Athens runs this business; related ones can be ticked in.
The company
AI-draftedVidavo develops digital-health and telemedicine software (Vida24) and delivers projects for health providers and insurers. Listed on EN.A. Growth, it publishes company-only accounts. H1 2026 revenue was €2.047m and profit €0.392m; services supplied 85.24% of revenue.
- 19/10/2026Bought 300 own shares at €10; total holding 5,339.12
- Jun 2026The AGM elects a five-member board for five years.3
- Apr 2026FY2025 results: revenue +97.4% and a return to profit.2
- Dec 2025Buyback begins: 200 shares at EUR 6.35.10
- Sep 2025189,443 new shares start trading.5
- Jan 2025Infotrust reports acquiring 22.35%; Thermi reports selling the same block.8,7
- 1.H1 2026 interim reportVidavo S.A. · 29/07/2026official
- 2.FY2025 annual reportVidavo S.A. · 28/04/2026official
- 3.AGM decisions 26 Jun 2026Vidavo S.A. · 26/06/2026official
- 4.Voting rights notice Mar 2026Vidavo S.A. · 30/03/2026official
- 5.New shares admitted to tradingVidavo S.A. · 10/09/2025official
- 6.Rights issue resultVidavo S.A. · 22/08/2025official
- 7.Infotrust purchase notice Jan 2025Vidavo S.A. · 03/02/2025official
- 8.Thermi sale notice Jan 2025Vidavo S.A. · 31/01/2025official
- 9.DRG platform press releaseVidavo S.A. · 06/03/2024official
- 10.Own-share notice 9 Dec 2025Vidavo S.A. · 12/12/2025official
- 11.Cash distributionsEuronext Athensofficial
- 12.Own shares: transaction 19 October 2026; 5,339 heldVidavoofficial